Full-Time
VP – Global Commercialization
Urology
Confirmed live in the last 24 hours
Telix Pharmaceuticals
201-500 employees
Develops targeted radiation therapies for cancer
Expert
Remote in USA
- Bachelor’s degree in marketing, business or life sciences required; Master’s degree preferred.
- 10+ years’ experience of sales/marketing/product management in the pharmaceutical/biotechnology industry with a focus in imaging, radiopharmaceuticals or oncology required
- Proven track record in launch strategy development and managing pre-launch activities to drive revenue and profits.
- Ability to conduct competitive environment analysis and understand market segments and customer needs to effectively translate into clear marketing requirements
- Ability to create business case justifications for new products and improvements of the product portfolio.
- High effectiveness in managing cross-functional teams without formal authority
- Experience in delivering finely tuned product marketing strategies
- Exceptional writing and editing skills, combined with strong presentation and public speaking skills
- Strong learning agility and a desire to gain new skills and experience.
- Deliver all Commercial/Pricing Strategy & Planning for Urology Assets
- Translate business strategy into product strategy
- Prioritizing and tracking investments across new product development initiatives
- Drive action throughout the organization to get urology assets to markets, and maximize market impact
- Drive strategy behind product profitability and commercial success
- Identifying and developing optimal revenue models, sales/distribution channels, pricing, and new product development strategies
- Drive market research, market access and competitive intelligence strategy across the asset portfolio
- Identifying and negotiating strategic partnerships including financial arrangements, customer sharing, and intellectual property rights
- Drive strategy and ownership the product roadmap for each asset in the portfolio
- Evaluate product functionality and drives present/future product direction
- Provide coaching and mentoring to members of the team to develop internal capability
- Engage in the Telix goal setting and performance development, and renumeration review processes
- Monitor and act on risks and opportunities, including escalating as appropriate
Telix Pharmaceuticals develops and sells products aimed at improving the diagnosis and treatment of cancer and rare diseases using targeted radiation. Their products work by delivering precise radiation to affected areas, which helps in making better treatment decisions and providing personalized therapy. Unlike many other biopharmaceutical companies, Telix focuses specifically on areas such as urologic oncology, neuro-oncology, musculoskeletal oncology, and bone marrow conditioning, addressing significant unmet medical needs. The company's goal is to enhance patient care while maintaining ethical practices and environmental responsibility, ensuring that they create sustainable value for patients, shareholders, and employees.
Company Stage
Grant
Total Funding
$63.5M
Headquarters
Melbourne, Australia
Founded
2015
6 month growth
↑ 12%1 year growth
↑ 27%2 year growth
↑ 90%
Simplify's Take
What believers are saying
- Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
- Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
- The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.
What critics are saying
- The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
- The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.
What makes Telix Pharmaceuticals unique
- Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
- The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
- Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.